Amylyx Pharmaceuticals Inc has a share price target of US$ 8, revenue growth forecast of -99.7%, and profit growth estimate of 46.2% for FY26, based on top 6 analyst calls.
Upgrade Your Plan
You need to upgrade your subscription plan to access this feature